Skip to main content
Livermore
Livermore
ZHEN

Harte Hanks Inc

HHS
Exchange
Nasdaq
Industry
Services-Direct Mail Advertising Services
SEC CIK
0000045919

No open-market purchases or sales by Harte Hanks Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $4.50M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Harte Hanks Inc changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of HHS: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders37140+4
Shares3.16M70.5K3.21M+121.4K (+3.9%)
Value$35.2M$805.0K$37.5M+$3.08M (+9.0%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Harte Hanks Inc at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to HHS in Q4 2022
InstitutionSharesValue% of portfolio
Krilogy Financial LLC62,500$730.6K0.07%
Citadel Advisors LLC33,211$388.2K0.00%
Cetera Advisors LLC17,570$205.4K0.00%
Bailard, Inc.11,716$137.0K0.01%
Susquehanna International Group, LLP10,350$121.0K0.00%
James Investment Research Inc2,100$25.0K0.00%
GWM Advisors LLC2,100$24.5K0.00%
Advisory Services Network, LLC1,000$11.7K0.00%

Sold out (4)

Institutions that held Harte Hanks Inc at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of HHS in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Walleye Capital LLC13,391$149.0K
Goldman Sachs Group Inc11,333$126.0K
Cubist Systematic Strategies, LLC10,561$118.0K
UBS Group AG910$10.0K

Not filed for Q4 2022 yet (1)

Institutions that held Harte Hanks Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HHS in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Eidelman Virant Capital70,500$805.0K